Patients Access solutions: the missing link that prevents biopharma i... We live in unprecedented times, where innovation in biosciences continues to accelerate.
Pharma Market Access Access solutions: the missing link that prevents biopharma i... We live in unprecedented times, where innovation in biosciences continues to accelerate.
News Pfizer takes 25-valent Prevnar follow-up into phase 3 Pfizer has upped the ante in the increasingly competitive market for pneumococcal vaccines with new data on a 25-valent candidate.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
